Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial

• Beatrice Barda,

  Affiliations Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

  ⨯
• Jean T. Coulibaly,

  Affiliations Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland, Unite´ de Formation et de Recherche Biosciences, Universite´ Felix Houphouët-Boigny, Abidjan, Côte d’Ivoire, Centre Suisse de Recherches Scientifiques en Côte d’Ivoire, Abidjan, Côte d’Ivoire

  ⨯
• Maxim Puchkov,

  Affiliation Department of Pharmaceutical Technology, University of Basel, Basel, Switzerland

  ⨯
• Jörg Huwyler,

  Affiliation Department of Pharmaceutical Technology, University of Basel, Basel, Switzerland

  ⨯
• Jan Hattendorf,

  Affiliation Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland

  ⨯
• Jennifer Keiser

  * E-mail: jennifer.keiser@unibas.ch

  Affiliations Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

  ⨯